Citrobacter koseri Cellulitis During Anti-CD20 Monoclonal Antibody (Ofatumumab) Treatment for B-cell Chronic Lymphocytic Leukaemia

被引：6
|
作者：
Kluger, Nicolas [1 ]
Cartron, Guillaume [2 ]
Bessis, Didier [1 ]
Guillot, Bernard [1 ]
Girard, Celine [1 ]
机构：
[1] Univ Montpellier 1, CHU Montpellier, Hop St Eloi, Dept Dermatol, FR-34295 Montpellier, France
[2] Univ Montpellier 1, CHU Montpellier, Hop Lapeyronie, Dept Haematol, FR-34295 Montpellier, France
来源：
ACTA DERMATO-VENEREOLOGICA | 2010年 / 90卷 / 01期
关键词：
GRAM-NEGATIVE FOLLICULITIS; DIVERSUS;
D O I：
10.2340/00015555-0762
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：99 / 100
页数：2
相关论文
共 50 条
  • [31] Chronic Lymphocytic Leukemia and anti-CD20 monoclonal antibodies
    Reslan, Lina
    Dalle, Stephane
    Mestas, Jean-Louis
    Tournebize, Cindy
    Dumontet, Charles
    BULLETIN DU CANCER, 2010, 97 : S60 - S60
  • [32] New Anti-CD20 Monoclonal Antibodies for the Treatment of B-Cell Lymphoid Malignancies
    Robak, Tadeusz
    Robak, Ewa
    BIODRUGS, 2011, 25 (01) : 13 - 25
  • [33] New Anti-CD20 Monoclonal Antibodies for the Treatment of B-Cell Lymphoid Malignancies
    Tadeusz Robak
    Ewa Robak
    BioDrugs, 2011, 25 : 13 - 25
  • [34] Severe side effects in patients with B-cell chronic lymphocytic leukemia (CLL) and lymphocytosis treated with the monoclonal anti-CD20 antibody rituximab.
    Winkler, U
    Jensen, M
    Manzke, O
    Tesch, H
    Bohlen, H
    Diehl, V
    Engert, A
    BLOOD, 1998, 92 (10) : 285B - 285B
  • [35] Successful treatment and re-treatment of resistant B-cell chronic lymphocytic leukemia with the monoclonal anti-CD 20 antibody rituximab
    Herold, M
    Schulze, A
    Härtwig, K
    Anger, G
    ANNALS OF HEMATOLOGY, 2000, 79 (06) : 332 - 335
  • [36] The efficacy and safety of B-cell depletion with anti-CD20 monoclonal antibody in adults with chronic immune thrombocytopenic purpura
    Cooper, N
    Stasi, R
    Cunningham-Rundles, SS
    Feuerstein, MA
    Leonard, JP
    Amadori, S
    Bussel, JB
    BRITISH JOURNAL OF HAEMATOLOGY, 2004, 125 (02) : 232 - 239
  • [37] Successful treatment and re-treatment of resistant B-cell chronic lymphocytic leukemia with the monoclonal anti-CD 20 antibody rituximab
    M. Herold
    A. Schulze
    K. Härtwig
    G. Anger
    Annals of Hematology, 2000, 79 : 332 - 335
  • [38] Ofatumumab, a second-generation anti-CD20 monoclonal antibody, for the treatment of lymphoproliferative and autoimmune disorders
    Castillo, Jorge
    Milani, Cannon
    Mendez-Allwood, Daniel
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2009, 18 (04) : 491 - 500
  • [39] A phase 1/2 trial of ublituximab, a novel anti-CD20 monoclonal antibody, in patients with B-cell non-Hodgkin lymphoma or chronic lymphocytic leukaemia previously exposed to rituximab
    Sawas, Ahmed
    Farber, Charles M.
    Schreeder, Marshall T.
    Khalil, Mazen Y.
    Mahadevan, Daruka
    Deng, Changchun
    Amengual, Jennifer E.
    Nikolinakos, Petros G.
    Kolesar, Jill M.
    Kuhn, John G.
    Sportelli, Peter
    Miskin, Hari P.
    O'Connor, Owen A.
    BRITISH JOURNAL OF HAEMATOLOGY, 2017, 177 (02) : 243 - 253
  • [40] Obinutuzumab: A Novel Anti-CD20 Monoclonal Antibody for Previously Untreated Chronic Lymphocytic Leukemia
    Shah, Arpita
    ANNALS OF PHARMACOTHERAPY, 2014, 48 (10) : 1356 - 1361
12345